Successful treatment of Von Zumbusch pustular psoriasis with infliximab Article

cited authors

  • Trent, JT; Kerdel, FA

fiu authors


  • Background: Von Zumbusch pustular psoriasis is a severe, generalized form of psoriasis. Patients may also suffer from systemic complications, such as fever, arthropathy, congestive heart failure, and infections, which can ultimately prove fatal. Generalized pustular psoriasis can often be recalcitrant, making treatment difficult. Objective: The purpose of this study was to demonstrate the efficacy of infliximab in treating generalized pustular psoriasis. Methods: Four consecutively admitted patients with generalized pustular psoriasis were treated with infliximab 5 mg/kg intravenous infusion. Results: After treatment with infliximab, white blood cell count, sedimentation rate, C-reactive protein, and vital signs normalized in all 4 patients within 24 h of the infusion. PASI scores on discharge had improved in all 4 patients. Conclusion: All 4 patients with generalized pustular psoriasis had rapid and positive responses to infliximab without any significant side effects. This experience adds support to the use of infliximab for generalized pustular psoriasis.

publication date

  • August 1, 2004

Digital Object Identifier (DOI)

start page

  • 224

end page

  • 228


  • 8


  • 4